FibroBiologics Inc. Common Stock logo

FibroBiologics Inc. Common Stock

FBLG | NASDAQ
Chart Builder DCF Calculator
$1.36
$0 (0.00%)
Sep 22, 2026, 1:17 PM ET · Market open
TTM
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
234K 234K 234K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
-234K -234K -234K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-16.73M -17.19M -16.65M -17.77M -16.09M -14.82M -13.74M -12.51M -11.21M -10.08M -8.89M -7.71M -7M -5.82M -4.47M -3.16M -1.82M -911K
Interest Income
133K 168K 247K 285K 291K 311K 251K 188K 109K 39K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-18.14M -18.68M -18.65M -18.5M -13.22M -7.67M -11.16M -17.78M -19.47M -22.53M -16.49M -8.29M -7.66M -6.52M -5.12M -3.6M -2.04M -1.02M
Net Income
-18.14M -18.68M -18.65M -18.5M -13.22M -7.67M -11.16M -17.78M -19.47M -22.53M -16.49M -8.29M -7.66M -6.52M -5.12M -3.6M -2.04M -1.02M
Selling & General & Admin
8.53M 8.61M 9.24M 9.81M 9.7M 9.5M 9.23M 8.59M 7.93M 7.22M 6.52M 5.77M 5.29M 4.42M 3.32M 2.36M 1.37M 684K
Research & Development
8.2M 8.58M 7.41M 7.97M 6.39M 5.32M 4.5M 3.92M 3.28M 2.85M 2.37M 1.94M 1.72M 1.4M 1.15M 802K 454K 227K
Other Expenses
-234K -234K -234K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
16.5M 16.95M 16.42M 17.77M 16.09M 14.82M 13.74M 12.51M 11.21M 10.08M 8.89M 7.71M 7M 5.82M 4.47M 3.16M 1.82M 911K
Interest Expense
201K 208K 204K 6K 11K 16K 20K 15K 10K 15K 146K 365K 586K 682.5K 654K 434K 213K 106.5K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
12.7M 17.19M 16.65M 17.77M 16.09M 14.82M 13.74M 12.51M 11.21M 10.08M 8.89M 7.71M 7M 5.82M 4.47M 3.16M 1.82M 911K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
6.27M 2.23M 2.23M 2.15M 1.93M 1.83M 1.74M 1.68M 1.64M 1.56M 1.59M 1.62M 1.62M 1.62M 1.52M 1.52M 1.41M 1.41M
Shares Outstanding (Diluted)
6.27M 2.23M 2.23M 2.15M 1.93M 1.83M 1.74M 1.68M 1.64M 1.56M 1.59M 1.62M 1.62M 1.62M 1.52M 1.52M 1.41M 1.41M
EPS (Basic)
-6.48 -8.22 -8.78 -9.58 -7.18 -4.18 -6.78 -11.20 -12.35 -14.28 -11.88 -6.68 -6.36 -5.75 -3.47 -2.47 -1.44 -0.72
EPS (Diluted)
-6.48 -8.22 -8.78 -9.58 -7.18 -4.18 -6.78 -11.20 -12.35 -14.28 -11.88 -6.68 -6.36 -5.75 -3.47 -2.47 -1.44 -0.72
EBITDA
-17.15M -17.56M -17.61M -17.74M -12.55M -7.05M -10.57M -17.21M -18.94M -22.04M -15.9M -7.53M -6.79M -4.73M -2.55M -1.34M n/a n/a
EBIT
-13.81M -18.47M -18.44M -18.5M -13.21M -7.65M -11.14M -17.76M -19.46M -22.52M -16.34M -7.93M -7.08M -5.84M -4.47M -3.16M -1.82M -911K
Depreciation & Amortization
702K 908K 832K 751K 663K 597K 573K 550K 519K 478K 437K 401K 289.14K 1.1M 1.92M 1.82M 1.82M 911K

© 2026 bestshares.com. All rights reserved.